Physician profile
Eric C Gechter
NPI 1104830413
$4,088.01
in general payments reported to CMS, 2019-2025
18 companies · $764 in 2025
The $764 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,099 · 2020: $217 · 2021: $308 · 2022: $279 · 2023: $945 · 2024: $476 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $966.99 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $779.35 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $556.67 | 2019-2021 | |
| Alcon Vision LLC | $501.94 | 2019-2024 | Rocklatan |
| Novartis Pharmaceuticals Corporation | $316.44 | 2019-2023 | |
| Allergan, INC. | $219.54 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $216.76 | 2019-2021 | |
| Oyster Point Pharma, INC. | $115.82 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $106.67 | 2019 | |
| Dompe US, INC. | $59.92 | 2022-2025 | Oxervate |
| Thea Pharma INC. | $58.18 | 2023-2025 | Iyuzeh |
| Harrow Eye, LLC | $44.44 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $36.56 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $32.63 | 2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $26.98 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.57 | 2023 | Vabysmo |
| Halozyme INC | $17.11 | 2019 | |
| Eyepoint US, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.